{
  "pmcid": "12379978",
  "sha256": "04b93c476e4101a66f2caa1134f3a90385a3cafd81f4021f33614bd68ebf5f6a",
  "timestamp_utc": "2025-11-09T23:35:31.117653+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.075237154150198,
    "reading_ease": 28.97198616600795,
    "word_count": 253
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Two-Stage Goal-Directed Crystalloid vs. Colloid Fluid Therapy in Laparoscopic Hepatectomy: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "The sample size was calculated to detect a 6-point difference in QoR-15 scores, assuming α = 0.05 and 1-β = 0.8."
      },
      "Participants": {
        "score": 2,
        "evidence": "116 patients aged 18-65 years, ASA I-III, were randomised 1:1 to receive either balanced salt solution with 6% hydroxyethyl starch (colloid group) or balanced salt solution alone (crystalloid group)."
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised 1:1 to receive either balanced salt solution with 6% hydroxyethyl starch (colloid group) or balanced salt solution alone (crystalloid group)."
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial assessed the effects of two-stage goal-directed crystalloid versus colloid fluid therapy on postoperative recovery quality in laparoscopic hepatectomy patients."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the Quality of Recovery-15 (QoR-15) score at 24 hours postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation used a random number table, with allocation concealed via opaque envelopes."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding included patients, outcome assessors, and statisticians."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "116 patients aged 18-65 years, ASA I-III, were randomised 1:1"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "58 patients were analysed per group using a per-protocol approach."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "No significant difference was found in QoR-15 scores between groups (p > 0.05)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: ChiCTR2400087179."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 23,
    "max_score": 25
  }
}